Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
Medical Devices not immune to recession worries - "We'll See!"
January 22, 2009
Medical devices not immune to recession worries | www.boston.com
While medical devices may not be immune to recession worries, they will not likely see their "worries" become reality as the discretionary consumer markets will. Hospitals will have an impact on device manufacturers however it will be for the same reason that consumers are having such an impact on the car manufacturers. Much of the non-imlantable products that are classified as medical devices are purchased by hospitals with "discretionary funds" or with credit and when the discretionary funds need to be conserved or the credit is not there, less products such as hospital beds and other smaller "medical devices" are purchased or their purchase is delayed. If the hospitals are going to affect medical device manufacturers it will be in these areas. I propose that the divisions of device companies that develop and manufacture implantable devices will not see the same effect and in fact may continue to prosper throughout the current situation.
Page : 11 to 1 of 1
Mobile Advertising Set To Soar ? Yes, But What Is The Engine For Growth
November 17, 2009
Roche Receives H1N1 FDA Emergency Use Authorization
November 16, 2009
From a physician point of view
November 16, 2009
Zetia Now Off Best Practices List for MI Prevention, But is Niaspan > Diet?
November 15, 2009
November 15, 2009
www.medscape.com
Rapid DNA Test to Detect Clostridium difficile Infection Approved by FDA Today
www.medicalnewstoday.com
Abbott To Acquire Evalve, Inc., A Leader In Minimally Invasive Cardiac Valve Repair Technology
www.pipelinereview.com
www.nytimes.com
www.docguide.com
FDA: Ongoing Omalizumab Study Shows Increased Number of Cardiovascular Events